Detection of early recurrence in HCC patients after TACE treatment with plasma cfDNA

Authors :: Xiao Du
Zhen Li
Henghui Zhang
Source :: Journal of Clinical Oncology. 36:e16146-e16146
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: e16146Background: Hepatocellular carcinoma (HCC) is the one of the most common prevalent fatal cancers worldwide with poor prognosis due to high incidence of recurrence. For patients with advanced ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Poor prognosis
Early Recurrence
business.industry
medicine.disease
digestive system diseases
Plasma.cfDNA
03 medical and health sciences
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Hepatocellular carcinoma
medicine
030211 gastroenterology & hepatology
High incidence
business

Full Text Access

Tools